(Source: H Lundbeck A/S) Valby, 2015-06-23 17:47 CEST (GLOBE NEWSWIRE) -- For non-US media only • A newly released pre-specified subgroup analysis from the QUALIFY** study shows that younger adult patients* improve significantly on aripiprazole once-monthly compared with paliperidone palmitate as measured by the Heinrichs-Carpenter Quality of Life Scale (QLS).1 • The positive effect of aripiprazole once-monthly is seen consistently in this subgroup of younger patients* across a range of effectiveness measures, suggesting that aripiprazole once-monthly treatment at a younger age may confer better treatment outcomes than paliperidone palmitate in patients with schizophrenia.1 • Results from...
↧